concept

ASTROCYTE REACTIVITY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ASTROCYTE REACTIVITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

137Connections

8Hypotheses

8Analyses

21Outgoing

50Incoming

0Experiments

9Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	ASTROCYTE REACTIVITY
Key Genes/Proteins	AMYLOID, DRP1, FGFR2, STING
Related Diseases	ALZHEIMER'S DISEASE, ASTROGLIOSIS, INFLAMMATION, MICROGLIAL ACTIVATION, NEUROINFLAMMATION
Related Pathways	CGAS-STING PATHWAY, COMPLEMENT CASCADE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Astrocyte Reactivity Mechanism

mechanism · 4559 words

→

Pathway Diagram

graph TD
    ASTROCYTE_REACTIVITY["ASTROCYTE REACTIVITY"]
    ASTROCYTE_REACTIVITY -->|"contributes to"| Neuroinflammation["Neuroinflammation"]
    ASTROCYTE_REACTIVITY -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
    A1AR["A1AR"] -->|"mediates"| ASTROCYTE_REACTIVITY
    STAT3["STAT3"] -->|"mediates"| ASTROCYTE_REACTIVITY
    CLU["CLU"] -->|"modulates"| ASTROCYTE_REACTIVITY
    DLL4["DLL4"] -->|"upregulates"| ASTROCYTE_REACTIVITY
    ASTROCYTES["ASTROCYTES"] -->|"activates"| ASTROCYTE_REACTIVITY
    SOD1["SOD1"] -->|"activates"| ASTROCYTE_REACTIVITY
    INFLAMMATION["INFLAMMATION"] -->|"contributes to"| ASTROCYTE_REACTIVITY

Outgoing (21)

Target	Relation	Type	Str
Microglial Responses	associated_with	process	0.95
Alzheimer's Disease	contributes_to	disease	0.90
Neuroinflammation	contributes_to	process	0.90
Astrocyte Senescence	associated_with	phenotype	0.85
Central Nervous System Degeneration	associated_with	disease	0.80
Central Nervous System Repair	associated_with	process	0.80
neuroinflammation	associated_with	phenotype	0.70
Alzheimer's disease	associated_with	disease	0.70
CGAS-STING PATHWAY	associated_with	pathway	0.65
CGAS-STING PATHWAY	regulates	pathway	0.65
TAU	causes	protein	0.65
TAU	interacts_with	protein	0.65
MICROGLIA	interacts_with	cell_type	0.65
ASTROGLIOSIS	causes	phenotype	0.65
ASTROGLIOSIS	targets	phenotype	0.65
MICROGLIAL ACTIVATION	activates	phenotype	0.65
AMYLOID	causes	protein	0.65
TGF-BETA SIGNALING	associated_with	pathway	0.50
COMPLEMENT CASCADE	associated_with	pathway	0.50
TEMPORAL LOBE	associated_with	brain_region	0.45
CORTEX	associated_with	brain_region	0.45

Incoming (116)

Source	Relation	Type	Str
Adenosine	associated_with	compound	0.95
A1AR	mediates	receptor	0.95
DLL4	upregulates	protein	0.90
ADENOSINE	triggers	compound	0.90
CLU	modulates	protein	0.90
STAT3	mediates	protein	0.90
White Matter Injury	causes	disease	0.90
Neuroinflammation	associated_with	process	0.80
BMAL1	regulates	protein	0.80
ASTROCYTES	regulates	cell_type	0.70
GFAP	biomarker_for	protein	0.70
STAT3	regulates	protein	0.70
apoe4	associated_with	disease	0.70
AQP4	biomarker_for	protein	0.70
COMPLEMENT CASCADE	inhibits	pathway	0.70
APOE4	activates	gene	0.70
PIEZO1	enhances	gene	0.70
STAT3	regulates	gene	0.70
APOE4	causes	gene	0.70
IL-6	enhances	gene	0.70
microglia	modulates	cell_type	0.70
GFAP	biomarker_for	gene	0.70
S100B	biomarker_for	gene	0.70
apoe4	causes	disease	0.70
apoe4	increases_risk	disease	0.70
STAT3	activates	protein	0.70
JAK/STAT3 signaling	regulates	pathway	0.70
GFAP	associated_with	gene	0.70
DRP1	activates	gene	0.65
NEUROINFLAMMATION	causes	phenotype	0.65
ALZHEIMER'S DISEASE	degrades	disease	0.65
INFLAMMATION	regulates	phenotype	0.65
STING	inhibits	gene	0.65
FGFR2	exacerbates	gene	0.65
ASTROCYTE	inhibits	cell_type	0.65
ASTROCYTE	treats	cell_type	0.65
ASTROCYTES	activates	gene	0.60
INFLAMMATION	contributes_to	gene	0.60
ASTROCYTE	contributes_to	gene	0.60
NEUROINFLAMMATION	contributes_to	gene	0.60
MICROGLIA ACTIVATION	activates	gene	0.60
IL6	activates	gene	0.60
HDAC3	inhibits	gene	0.60
PSD95	activates	gene	0.60
SOD1	activates	gene	0.60
GAIN	activates	gene	0.60
TNF	activates	gene	0.60
GFAP	activates	gene	0.60
PHAGOCYTOSIS	activates	gene	0.60
COMPLEMENT	activates	gene	0.60

Targeting Hypotheses (8)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vuln	0.690	neurodegeneration	Cell type vulnerability debate in Alzhei
whether the Astrocyte reactivity subtypes in neurodegenerati	0.604	neurodegeneration	Methodology challenge: notebook 'Astrocy
Stratified falsifiers should govern Methodology challenge: n	0.591	neurodegeneration	Methodology challenge: notebook 'Astrocy
Astrocyte reactivity subtypes in neurodegeneration — Rich An	0.577	neurodegeneration	Methodology challenge: notebook 'Astrocy
Astrocyte Reactivity Subtype Targeting GABA Synthesis	0.558	neurodegeneration	Methodology challenge: dataset 'Allen Br

Astrocyte Reactivity Reprogramming via A1/A2 Phenotype Modul	0.550	neurodegeneration	Test
Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss	0.508	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Spinal Cord Astrocyte Reactivity Convergence	0.455	neuroinflammation	Why do clinical manifestations overlap d

Mentioning Analyses (8)

Scientific analyses that reference this entity

scRNA-seq Processing and Cell Type Annotation of AD Brain

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.618

Which neural cell types exhibit the most pronounced gene expression alterations

neurodegeneration | 2026-04-11 | 0 hypotheses

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

neurodegeneration | 2026-04-10 | 0 hypotheses

Why do clinical manifestations overlap despite distinct underlying etiologies in

neuroinflammation | 2026-04-08 | 7 hypotheses Top: 0.455

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety throu

neurodegeneration | 2026-04-08 | 1 hypotheses Top: 0.380

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (9)

Multi-agent debates referencing this entity

Which cell types show the greatest vulnerability in Alzheimer's disease accordin

closed · Rounds: 4 · Score: 0.75 · 2026-04-22

The core debate question remains unresolved - whether intrinsic tau conformation

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Can standardized scRNA-seq processing and automated annotation identify novel ce

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The debate generated therapeutic hypotheses targeting different cell types but n

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

Does the hybrid DAM + interferon-response microglial population represent a nove

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The study reports that complement-mediated synaptic elimination produces both co

closed · Rounds: 4 · Score: 0.83 · 2026-04-09

The abstract notes that clinical presentations overlap across different myelopat

closed · Rounds: 4 · Score: 0.86 · 2026-04-09

Microglia activate astrocytes via IL-1alpha/TNF/C1q, and reactive astrocytes fee

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

What are the mechanisms underlying astrocyte reactivity subtypes in neurodegener

closed · Rounds: 5 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning ASTROCYTE REACTIVITY in their description or question text

Astrocyte Reactivity Reprogramming via A1/A2 Phenotype Modulation

Score: 0.550 · neurodegeneration · 2026-04-28

Reactive astrocytes acquire neurotoxic A1 or neuroprotective A2 phenotypes in neurodegeneration. Blocking A1 inducers (I

Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss in Alzheimer's Dise

Score: 0.508 · neurodegeneration · 2026-04-26

Lipocalin-2 (LCN2), secreted by reactive astrocytes, binds to astrocytic LCN2R and triggers iron-dependent ferroptosis o

Spinal Cord Astrocyte Reactivity Convergence

Score: 0.455 · neuroinflammation · 2026-04-27

Inflammatory myelopathies converge through activation of shared astrocyte reactivity program controlled by JAK/STAT3 sig